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General Aspects of Cadmium: Transport,
Uptake and Metabolism bythe Kidney
by Monica Nordberg*
Cadmium taken up fromlung and gastrointestinal tractis transported viablood to liver
and kidney. On long-term exposure to cadmium, renal tubular dysfunction develops in
humans and experimental animals. Data from animal experiments demonstrate that
initially after exposure cadmium in blood is bound to albumin and proteins with higher
molecular weight. Such cadmium is mainly taken up in liver. For a few days after
exposure cadmium exists as metallothionein in plasma and blood cells. After both single
andlong-term administration ofcadmium boundtometallothionein, cadmium istaken up
by the kidney. The concentration of metallothionein-bound cadmium in plasma is quite
low due to continuous renal clearance. Cadmium from metallothionein is taken up in
renal tubules by pinocytosis and subsequently degraded in lysosomes, thereby releasing
cadmium which stimulates de novo synthesis of metallothionein but also binds to reab-
sorbed metallothionein. Catabolizing and rebinding are continuous and prevent excre-
tion of cadmium. Because of differences in transport, renal metabolic handling forms of
cadmium are also different for different forms of cadmium administered and rate of
administration. A single dose ofmetallothionein-bound cadmium given intravenously is
almost immediately and completely taken up in the renal tubule. Under such conditions,
resynthesis and rebinding processes are insufficient to sequester cadmium from sensitive
tissue receptors, and renal damage occurs at total tissue concentrations much lower than
when renal cadmium concentrations rise slowly. This explains the wide range (10-200 jg
Cd/g wet weight) of cadmium in the renal cortex that associated with renal tubular
dysfunction in experimental animals.
Introduction
Cadmium is taken up from the lung and gastro-
intestinal tract and transported via the blood to
liver and kidney. On long-term exposure to cad-
mium, renal tubular dysfunction may develop
both in humans and experimental animals (1).
Data from animal experiments demonstrate that
initially after exposure cadmium in blood is
bound to albumin and proteins with a molecular
weighthigher than albumin (2). Such cadmium is
mainly taken up by the liver. Cadmium induces
the synthesis of metallothionein in liver and
other tissues (Table 1). Metallothionein is a low
molecular weight protein involved in cadmium,
zinc and copper metabolism (3) and has a molecu-
lar weight ofaround 6500 (Table 1). Metallothio-
nein may serve in a protective function by bind-
ing cadmium in a stable biocomplex. In this way
interference with other cellular components is
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decreased and the acute effects normally seen in
acute exposure can be prevented. Data have been
presented in support ofthis hypothesis, and such
a course ofevents was demonstrated by Nordberg
(4) in testicular and liver tissue.
Since proteins ofa molecular weight similar to
that of metallothionein are completely filtered
through the glomerular membrane, metallothio-
nein-bound cadmium when released into plasma
will be filtered into renal tubular fluid. Such a
mechanicsm and a subsequent tubular reabsorp-
tion was originally advancedby Piscator (5) as an
explanation for the prominent accumulation of
cadmium in kidneys of animals and human be-
ings, chronically exposed to cadmium. These the-
ories have been further discussed and developed
by Nordberg (6) and reviewed by Friberg et al. (1)
and Nordberg (2). The present studies aimed at
confirmingthese theories and included investiga-
tions of the distribution of cadmium to different
forms ofmetallothionein as well as assessment of
adverse effects ofsuch injections upon renal tubu-
lar cells. Autoradiographic techniques, metalTable 1. Characteristics, occurrence and function of
metallothionein.
Physical characteristics
Molecular weight 6000-7000
Cd, Zn, Cu, Hg content 5-10%
Amino acids 30% cystine; no aromatics; no
histidine
UV absorption 254 nm
Occurrence Liver, kidney, plasma,
erythrocytes
Functions Storage ofmetals
Detoxification ofmetals
Protection from metal toxicity
Thansport ofmetals
Metabolism ofessential
metals
Immune response
analysis andvarious biochemical separation tech-
niques have been used to gain information for
identification of cadmium binding in the body
with special interest focused on the transport,
uptake and metabolism of cadmium by the kid-
ney.
Material and Methods
In order to study the distribution of cadmium
the following study was designed. Twenty-five
male CBA mice obtained from Anticimex, Swe-
den (17-20 g), were divided into five groups and
given a single subcutaneous injection ofcadmium
as radiolabeled cadmium chloride, 1 mg Cdl/kg
bodyweight, 100gCi/mouse of109Cd. Immediately
after exposure and before killing, the mice were
taken for whole-body counting. Under slight
ether anesthesia the animalswere killedby cervi-
cal dislocation. They were killed after different
time intervals: 20 min (n = 4) and4 (n = 4), 24 (n
= 4), 48 (n = 4), 96 (n = 4) and 192 (n = 5) hr.
Liver, kidney, and testis were taken for metal
analysis. For further study of the samples gel
chromatography was performed on supernatants
after ultracentrifugation (105,000g) oftissue ho-
mogenates.
Distribution of Cadmium in Blood
Whole blood was drawn from the eye vessels
with heparinized capillaries, weighed and
counted for radioactivity. Plasma and blood cells
were separated by centrifugation. A few samples
were totally excludedfromthe study due to hemo-
lysis. Radioactivity was counted in plasma and
blood cells. Blood cells were washed by adding
0.9% saline, and the radioactivity was counted.
The cells were hemolyzed by adding deionized
water and freezing at -60°C. The cadmium con-
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FIGURE 1. Concentrations of cadmium in (0) plasma and (@)
bloodcells, in mice given asingle subcutaneous injection of
1O9CdCl2 (1 mg ofCd/kg body weight) and killed at various
times after injection. Vertical bars indicate the standard
error and the circles indicate mean values. From Nordberg
(2).
centrations ofblood cells andplasma are shown in
Figure 1. Rapid clearance ofcadmium was seen in
plasma between 4 and 48 hr. In the same time
interval an increase in cadmium concentration in
the blood cells was observed.
Plasma and blood cells were taken for gel chro-
matography. A 355 x 26 mm column was packed
with Sephadex G-75 superfine gel. Elution was
carriedoutwith 0.01 MThisbuffer in 0.05 MNaCl
(pH 8.0) at a flow rate of 14 mL/hr, and 5 mL
fractions were collected. The optical density at
254 nm was continuously monitored.
The distribution pattern of cadmium after gel
chromatography ofplasma and hemolyzates from
animals killed 20 min (plasma only) and 96 and
192 hr after injection is seen in Figures 2 and 3,
respectively. Both high and low molecular weight
fractions contained cadmium. Data from these
animal experiments demonstrate that initially
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FIGURE 2. Gel chromatography on Sephadex G-75 of plasma
from mice given a single subcutaneous injection of
1o9CdCl2 (1 mg Cd/kg): (A) 20 min after injection, 20,000
cpm = 45.4 ng ofCd; (B) 96 hr after injection, 100 cpm =
0.028 ng ofCd; (C) 192 hr after injection, 100 cpm = 0.028
ng ofCd. Column dimensions were 355 x 26 mm. Elution
with 0.01 M This buffer in 0.05 M NaCl (pH 8.0) at a flow
rate of 14 mb/hr. Volume offractions: 5 mL OD at 254 nm
was continuously monitored. From Nordberg (2).
after exposure cadmium in blood is bound to al-
bumin andproteins with molecularweighthigher
than that ofalbumin. However, cadmium was not
found to be bound particularly to fractions con-
taining hemoglobin. Low molecular weight frac-
tions (fractions of 22-25) contained a major part
ofthe cadmium, and the metal was thus likely to
be bound to metallothionein. This evidence sup-
ports the idea that cadmium is bound to metal-
lothionein in plasma and blood cells (7). Further
evidence for the existence of increased metal-
lothionein concentrations in blood plasma in ani-
mals and man after repeated exposure to cad-
mium has been provided by a radioimmunochem-
ical method (8,9).
Low Molecular Weight Cadmium
Binding Protein in Blood Cells
The indicated low molecular weight fractions
(metallothionein) from blood cell hemolyzate
were pooled and concentrated on an Amicon cell
witha UM-2 filter. The concentrated protein solu-
tion was injected intravenously (IV) into mice in
order to study the distribution of cadmium in
mice.
The protein solution fromblood cell hemolyzate
was further characterized by isoelectric focusing
according to a method described previously (10).
Cadmium was discovered to be bound to the pro-
tein appearing at a pH slightly below 6. Zinc
analyses, performed by atomic absorption spec-
trophotometry, showed that the fractions ob-
tained by isoelectric focusing ofcadmium binding
protein from hemolyzates did inded contain zinc
(Fig. 4). In accordance with aprevious report (11),
pI for metallothionein increases with increasing
amount ofzinc. This piece ofevidence gives some
support to the hypothesis that cadmium in blood
exists mostly as metallothionein with zinc as the
dominating metal. However, the possibility can-
not be entirely ruled out that binding occurs to
some other low molecular weight zinc-containing
protein, since identification ofthe protein is still
incomplete. Mice were intravenously injected
with these solutions (approximately 2 ng Cd/
mouse). The animals were divided into groups of
two to five animals. They were killed 4 and 96 hr
later. Animals intravenously injected with
19CdCl2 served as controls. The animals were
subjected to whole body counting which was per-
formed immediately after injection and just be-
fore killing. Animals were put in metabolism
cages, and urine was collected 4 hr after injection
and 24 hr before killing. Animals injected with
cadmium bound to protein isolated from mice
killed 96 hr after subcutaneous (SC) Cd injection
had kidney values of 66.3 and 58.9% of the IV
dose, dependingupon observation time, 4 or 96 hr.
Corresponding figures for animals injected with
protein isolated from hemolyzate of animals
killed after 192 hr were 68.5 and 72.2% of the
dose (Table 2). These values are about 10 times
those seen in animals injected with 109CdC12. Au-
toradiography performed on mice killed 4 hr after
IV injection ofCd-bindingproteinfrom blood cells
showed accumulation of cadmium in the kidney
cortex. High cadmium concentrations were seen
in the liver ofthose given cadmium chloride (Fig.
5). The autoradiographic patterns were similar to
those shown in mice injected with hepatic metal-
lothionein (Fig. 6).
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FIGURE 3. Gel chromatography on Sephadex G-75 ofhemolyzate ofblood cells from mice given a single subcutaneous injection of
'09CdCl2 (1 mgCd/kg): (A) 96 hr after injection; (B) 192 hrafter injection. Column dimensions were 355 x 26 mm. Elutionwith
0.01 MTrisbufferin0.05MNaCl (pH8.0) at aflowrateof14mL/hr. Volumeoffractions = 5mL. OD at254 nm wascontinuously
monitored. The indicated fractions were pooled, concentrated and taken for further studies. From Nordberg (2).
These findings showed that a few days after
exposure, cadmium exists in abiocomplex sinmilar
to metallothionein both in plasma and in blood
cells. Preliminary results from further separation
ofblood cells (Nuottaniemi, to be published) into
lymphocytes and erythrocytes by Ficoll separa-
tion of blood from cadmium single subcutane-
ously dosed rats and CBA mice showed that cad-
mium was present mainly in the erythrocytes,
with almost no cadmium in the lymphocytes.
Cadmium uptake in blood cells may occur either
directly from plasma or via the bone marrow (12).
Relationship to Toxicity of Cd
Binding to Metallothionein
Single as well as long-term parenteral adminis-
tration (13) of metallothionein-bound cadmium
gives rise to an uptake ofcadmium in the kidney.
Metallothionein, the protein that stores cadmium
in the body, is found to act as a detoxifying agent
for cadmium and is involved in the transport of
cadmium from liver via blood to kidney. These
mechanisms may explain both the protective ef-
fect (4) against acute cadmium toxicity, e.g., the
testicular damage, and the elicitation of long-
termtoxicity, i.e., effect upon thekidney (14). The
renal damage was actually observed as a side
effect when using metallothionein as a protective
agent against testicular necrosis (4).
Metabolism by the Kidney and
Renal Toxicity
Subcutaneous injection of metallothionein in
mice atdoses of6, 2.5, 1.5, 1.3 and 1.1 mgofCd/kg
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Thble 2. Amount ofcadmium in the kidney ofmice
injected intravenously with hemolyzate ofmice.
Cadmium Time after
compound injection % ofamount injected
l09Cd Cl2 4 hr 6.1
6.9
10.1
6.5
4.5
Mean 6.8
96hr 6.2
6.6
Mean 6.4
109Cd-binding 4 hr 55.9
protein from 96-hr 74.9
hemolyzate 68.2
Mean 67.4
96 hr 67.4
50.3
Mean 58.9
109Cd-binding 4 hr 75.9
protein from 192-hr 66.6
hemolyzate 63.0
Mean 68.5
96hr 71.3
73.1
Mean 72.2
body weight and control animals showed a
marked difference of cadmium toxicity. Animals
in the metallothionein group did not survive
these doses of cadmium (14). The histological
examination showed dose-dependent renal dam-
age in animals exposed to cadmium (0.05-0.6 mg
Cd/kg body weight) as metallothionein (14) and a
decreased urinary excretion ofcreatinine was re-
corded. This provides evidence that the death of
the animals in the high Cd-metallothionein dose
group was due to renal damage. An experiment
(Table 3) withdoses of0.03, 0.08 and 0.075 mgCd/
kg as metallothionein or CdCl2 showed that 4 hr
after injection 95% of injected dose was accumu-
lated in the kidney when pure metallothionein
was administered (15).
The concentration of metallothionein-bound
cadmium inplasma isquite lowdue to continuous
renal clearance. Cadmium-metallothionein is
taken up in the renal tubule by pinocytosis (16,
17) and may subsequently be degraded in the
lysosomes, thereby releasing cadmium. This the-
ory has been confirmed in several papers by
Fowler et al. (18). Cherian et al. (19) have pre-
sented evidence that, according to our interpreta-
tion, is not contradictory to the findings ofFowler
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FIGURE 4. Isoelectric focusing ofpooled fractions indicated in
Fig. 3B. Carried outby use ofa sucrose gradient 0-50% (w/
v). The following carrier ampholytes were used (Ampho-
line 40 % w/v): in the less dense fraction, 0.4 mL pH 4-6
and 1.6 mL pH 3.5-5; in the more dense fraction, 0.1 mL
pH 3.5-5,0.4 mL pH4-6 and 0.4 mL pH 6-8.
et al. (18). Intracellularly released cadmium may
subsequently stimulate de novo synthesis ofme-
tallothionein but may also bind to reabsorbed
metallothionein that has been transported from
the liver. The mechanism for release ofliver me-
tallothionein to blood has not been studied.
Uptake of cadmium in the kidney has been
demonstrated by autoradiographic study of mice
intravenously injected with cadmium as metal-
lothionein isolated from livers of rabbit and
mouse and from hemolyzate of mouse. Neither
specifies differences nor differences in source for
isolation of metallothionein were observed. A
prominent uptake by the cells in kidney cortex
Table 3. Amount ofl09Cd found in kidneys ofmice in-
jected intravenously with l19Cd-MT1, l09Cd-BP and
109CdC12.
l09Cd in kidneys, % ofdosea
Time lO9Cd-MT1 lO9Cd-BP 1O9CdCl2
after
injection L H I L H I
5 min 45.0 43.5 30.8 2.9
31.8 32.3 34.4 2.3 3.1 3.2
39.0 38.9 2.3 4.0 3.2
Mean 38.6 38.2 32.6 2.5 3.6 3.2
4 hr 82.1 76.8 10.7 6.5 4.9
93.4 89.5 43.7 5.8 6.6 4.6
107.0 84.0 56.4 5.0 6.7
99.1 73.6
Mean 95.4 81.0 50.1 7.2 6.6 4.8
aDose levels: L = low dose (0.03 mg Cd/kg); H = high dose
(0.08 mg Cd/kg); I = intermediate dose (0.075 mg Cd/kg).
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FIGURE 7. Gel chromatography on G-75 Sephadex ofkidneys from mice exposed to: (left) 1"CdCl2 and (right) 109CdBP: (A) 5 min
after injection; (B) 4hrafter injection; (C) 24hrafter injection; (D) 96 hrafter injection. Columndimensions were 371 x 26mm.
Elution wascarried outwith0.01 MTrisbufferin0.05MNaCl, pH8.0, at aflowrateof14mL/hr. volumeoffractions 5 mL. From
Nordberg (2).
was observed (Figs. 5 and 6). In control animals
injected intravenously with radiolabeled cad-
mium chloride, cadmium was mainly distributed
to the liver. Kidneys from animals exposed to
crude metallothionein (15) subjected to gel chro-
matography showed that for 109CdBP most of the
radioactivity was in the low molecular weight
fractions 5 min after injection (Fig. 7). At 24 hr,
less cadmium was detected in the low molecular
weight fractions. At 96 hr the distribution pat-
tern was more similar to that of 5 min. Further
studies were made by Squibb and Fowler (20).
Kidneys of cadmium-exposed rabbits preserved
for transplantation did not lose cadmium as me-
tallothionein during storage (21, 22) which
showed that metallothionein is a stable biocom-
pound ofcadmium.
Concluding Remarks
From the data presented it is obvious that,
because of differences in transport, the ability of
the kidney to handle metabolism of cadmium is
entirely different for different forms of cadmium
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originally administered and depends also on the
rate ofadministration. Cadmium in bloodplasma
as well as in blood cells is to a large extent bound
to a low molecular weightprotein. These observa-
tions have been confirmed by other investigators
(13,19,23). Whenasingle dose ofmetallothionein-
boundcadmium is given intravenously, an almost
immediate and complete uptake occurs in the
renal tubule. It is conceivable that under such
conditions the resynthesis and rebinding proc-
esses are insufficient to sequester cadmium from
sensitive tissue receptors, and renal damage oc-
curs at total tissue concentrations much lower
than when renal cadmium concentrations rise
slowly. This explains the wide range ofcadmium
concentration (10-200 gg Cd/g wet weight) in the
renal cortex associated with renal tubular dys-
function in experimental animals.
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